ID
37648
Description
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Mots-clés
Versions (1)
- 13/08/2019 13/08/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
13 août 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Cycle 7
- StudyEvent: ODM
Description
Day 1-5
Alias
- UMLS CUI-1
- C0008976
- UMLS CUI-2
- C0449438
Description
Clinical Trials, Delay of chemotherapy
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C1299577
Description
Clinical Trials, Delay of chemotherapy, Reason and justification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C1299577
- UMLS CUI [1,3]
- C0566251
Description
Clinical Trials, Delay of chemotherapy, Reason and justification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C1299577
- UMLS CUI [1,3]
- C0566251
Description
Administration of study medication topotecan (oral)
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0146224
- UMLS CUI-3
- C3469597
Description
Experimental drug, Topotecan, Administration of medication, Day
Type de données
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C3469597
- UMLS CUI [1,4]
- C0439228
Description
Experimental drug, Topotecan, Administration of medication, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C3469597
- UMLS CUI [1,4]
- C0011008
Description
Experimental drug, Topotecan, Daily Dose, Planned
Type de données
text
Unités de mesure
- mg/m2
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C2348070
- UMLS CUI [1,4]
- C1301732
Description
Experimental drug, Topotecan, Dosage
Type de données
integer
Unités de mesure
- mg
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C0178602
Description
Administration of study medication topotecan (oral)
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0146224
- UMLS CUI-3
- C3469597
Description
Experimental drug, Topotecan, Dispense, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C1880359
- UMLS CUI [1,4]
- C0011008
Description
Experimental drug, Topotecan, Capsule, Dispensed Amount
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C0006935
- UMLS CUI [1,4]
- C0805077
Description
Experimental drug, Topotecan, Capsule, Dispensed Amount
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C0006935
- UMLS CUI [1,4]
- C0805077
Description
Experimental drug, Topotecan, Returned, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C0332156
- UMLS CUI [1,4]
- C0011008
Description
Experimental drug, Topotecan, Capsule, Returned Amount
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C0006935
- UMLS CUI [1,4]
- C2699071
Description
Experimental drug, Topotecan, Capsule, Returned Amount
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C0006935
- UMLS CUI [1,4]
- C2699071
Description
Experimental drug, Topotecan, Medication dose changed
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C1608430
Description
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C1608430
- UMLS CUI [1,4]
- C0566251
Description
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0146224
- UMLS CUI [1,3]
- C1608430
- UMLS CUI [1,4]
- C0566251
Similar models
Cycle 7
- StudyEvent: ODM
C1299577 (UMLS CUI [1,2])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C1301732 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
C0146224 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0332156 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])